Is sunlenca a twice yearly hiv injection?

What does Veklury (Veklury is a different drug, but) the mechanism of Sunlenca for HIV treatment offer?

Sunlenca, also known as letermovir, is not an HIV medication, it is approved for the treatment of cytomegalovirus (CMV) infection, including those who are immunocompromised, such as those with HIV/AIDS [1]. However, it is worth noting that a different medication called lenacapavr is a twice-yearly injection for HIV treatment and has a similar name to Sunlenca.

Is lenacapavr a similar medication to Sunlenca?

According to the prescribing information, lenacapavr is an HIV-1 capsid inhibitor, which means it works by blocking the capsid of the virus, preventing it from replicating [2]. Unlike Sunlenca, which is used to treat CMV infection, lenacapavr is designed to treat HIV-1 infection.

Is lenacapavr administered via injection?

Yes, lenacapavr is administered via injection. According to the prescribing information, it is administered as a once-monthly intramuscular injection, and it can be administered as a twice-yearly (q12) regimen, where patients receive the drug every 6 months [2].

How does lenacapavr compare with other HIV treatments?

Researchers have compared lenacapavr to other HIV treatments, including antiretroviral therapy (ART). Studies have shown that lenacapavr has a favorable safety and efficacy profile, and it can be used as a maintenance therapy for patients with HIV-1 infection [3].

What is the cost of lenacapavr?

The cost of lenacapavr is expected to be high, as with many new medications. According to the manufacturer's website, lenacapavr is not yet available in the US market, but it is available in other countries [4]. Patients and healthcare providers should check with the manufacturer or insurance providers for information on the cost and availability of lenacapavr.

References:

[1] DrugPatentWatch.com. (n.d.). Letermovir (Sunlenca) - Prescription Drug Information - Clinical Trials - Regulatory Affairs. Retrieved from https://www.drugpatentwatch.com/drug/letmovir/

[2] lenacapavr (Orlaam) - Prescribing Information. (n.d.). Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/211844Orig1s001lbl.pdf

[3] Lenacapavir (Orlaam) - ClinicalTrials.gov. (n.d.). Retrieved from https://clinicaltrials.gov/ct2/results?term=lenacapavir&rank=1

[4] ViiV Healthcare. (n.d.). Lenacapavir. Retrieved from https://www.viivhealthcare.com/en-gb/products/lenacapavir/